Highlights: EULAR's new guidelines address non-pharmacological approaches for systemic lupus erythematosus and systemic sclerosis, focusing on individualized patient care ...

Lifestyle approaches, including physical activity and smoking cessation, should complement medical therapy in patients with rheumatic and musculoskeletal diseases, according to data presented at ...

EULAR hopes these new recommendations will provide guidance on non-pharmacological interventions for people with SLE or SSc, and promote their use alongside pharmacotherapy to improve overall ...

The first interim results from the ongoing ASTIS trial of stem-cell transplantation in scleroderma look "encouraging," say the investigators. (EULAR 2004 meeting.) ...

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress. News provided by.

These data are being presented in three oral presentations at the ongoing European Alliance of Associations for Rheumatology (EULAR) 2025 Congress, which is being held from June 11-14, 2025, in ...

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress. News provided by.

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress. News provided by.

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress. News provided by.